✦ LIBER ✦

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Scribed by Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fujiwara; Kazuhiko Yamada; Tomohide Tamura; Hiroyuki Watanabe; Yu-Nien Sun; Michael B. Bass; Mitsuo Seki

Publisher: Springer
Year: 2010
Tongue: English
Weight: 364 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1243-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of motesanib in Japanese

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

✍ Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Mas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 302 KB

A Japanese phase I study of continuous o

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors

✍ Toshiaki Saeki; Shigemitsu Takashima; Masanori Terashima; Atsushi Satoh; Masakaz 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 229 KB

Phase 1 study of MLN8054, a selective in

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

Phase 1 study of conatumumab, a pro-apop

Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors

✍ T. Doi; H. Murakami; A. Ohtsu; N. Fuse; T. Yoshino; N. Yamamoto; N. Boku; Y. Ono 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 237 KB

Phase 1 pharmacokinetic and drug-interac

Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors

✍ Faye M. Johnson; Shruti Agrawal; Howard Burris; Lee Rosen; Navneet Dhillon; Davi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Phase I trial of the matrix metalloprote

Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

✍ Elisabeth I. Heath; Seamus O'Reilly; Rachel Humphrey; Pavur Sundaresan; Ross C. 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 90 KB